Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bayever

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|July 1, 1997
Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiationB G Gordon, P I Warkentin, S E Strandjord, et al.
Gynecologic Oncology|May 30, 2009
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II studyD S McMeekin, A Lisyanskaya, M Crispens, et al.
Diagnostic Immunology|January 1, 1986
Serial evaluation of lymphocyte function in bone marrow-grafted patientsA D D'Andrea, E Bayever, K M Haines, et al.
Journal of Neuro-Oncology|December 1, 1990
High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescenceJ L Finlay, C August, R Packer, et al.
Bone Marrow Transplantation|June 1, 1996
A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastomaN Kamani, C S August, N Bunin, et al.
Journal of Inherited Metabolic Disease|January 1, 1992
Bone marrow transplantation for Niemann-Pick type IA diseaseE Bayever, N Kamani, P Ferreira, et al.
Progress in Clinical and Biological Research|January 1, 1994
Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemiaM R Bishop, P I Warkentin, J D Jackson, et al.
Leukemia & Lymphoma|January 1, 1994
Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequencesE Bayever, K M Haines, P L Iversen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2008
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignanciesM von Mehren, R J Schilder, J D Cheng, et al.
Antisense Research and Development|January 1, 1993
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|July 1, 1997
Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiationB G Gordon, P I Warkentin, S E Strandjord, et al.
Gynecologic Oncology|May 30, 2009
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II studyD S McMeekin, A Lisyanskaya, M Crispens, et al.
Diagnostic Immunology|January 1, 1986
Serial evaluation of lymphocyte function in bone marrow-grafted patientsA D D'Andrea, E Bayever, K M Haines, et al.
Journal of Neuro-Oncology|December 1, 1990
High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescenceJ L Finlay, C August, R Packer, et al.
Bone Marrow Transplantation|June 1, 1996
A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastomaN Kamani, C S August, N Bunin, et al.
Journal of Inherited Metabolic Disease|January 1, 1992
Bone marrow transplantation for Niemann-Pick type IA diseaseE Bayever, N Kamani, P Ferreira, et al.
Progress in Clinical and Biological Research|January 1, 1994
Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemiaM R Bishop, P I Warkentin, J D Jackson, et al.
Leukemia & Lymphoma|January 1, 1994
Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequencesE Bayever, K M Haines, P L Iversen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2008
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignanciesM von Mehren, R J Schilder, J D Cheng, et al.
Antisense Research and Development|January 1, 1993
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.
Pageof 4